Skip to content

Fascial Closure Technique After Gynecologic Laparoscopic Surgery and Postoperative Pain

Fascial Closure Technique After Gynecologic Laparoscopic Surgery and Postoperative Pain: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04765306
Enrollment
123
Registered
2021-02-21
Start date
2021-03-05
Completion date
2022-04-14
Last updated
2022-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Postoperative

Brief summary

Our study aims to determine postoperative pain outcomes when comparing port site \> 10 mm fascial closure with traditional direct closure versus use of laparoscopic fascial closure device in patients undergoing minimally invasive gynecologic surgery via laparoscopic or robotic techniques. Pain outcomes will be measured using the visual analog scale.

Interventions

DEVICETraditional Direct Fascial Closure

Fascial closure using traditional surgical instruments and suture without laparoscopic guidance.

Fascial closure using a fascial closure device under direct laparoscopic guidance.

Sponsors

Jessica G Putman
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

This will be a prospective, singled-blinded, randomized controlled study. Eligible patients who provide consent will be randomized into one of two arms either undergoing fascial closure with a fascial closure device or traditional direct closure on the day of surgery. Every patient will have equal probability of being assigned to either study arm. The patients will be blinded to which study arm they have been assigned to, but providers will be aware due to the nature of study topic.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients aged 18 or older. * Any patient undergoing laparoscopic gynecologic surgery with one left upper quadrant port site \> 10 mm via either robotic or traditional laparoscopic techniques for any indication including abnormal bleeding, pelvic pain, gynecologic cancer, uterine fibroids, etc. Procedures performed will include but not be limited to hysterectomy, bilateral or unilateral salpingoophorectomy, ovarian cystectomy, and pelvic floor support procedures. * Patients willing and able to give informed consent. * Patients capable and willing to return for follow up and complete pain diaries.

Exclusion criteria

* Patients unable to return for follow up. * Patients undergoing laparoscopic surgery that requires conversion to laparotomy. * Patients undergoing laparoscopic surgery that does not require a port site \>10 mm.

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain scores via Visual Analog ScaleThrough 2 weeks postoperativelyA 20 mm difference in VAS score and a 2-unit difference on a 10-point pain scale have been described as a clinically significant difference between treatment groups.

Secondary

MeasureTime frameDescription
Quantity of narcotics consumed in postoperative periodThrough 2 weeks postoperativelyNumber of tablets of narcotics consumed in postoperative period
Length of hospital stayThrough study completion, up to 6 monthsLength of hospital stay in days from day of surgery until discharge home
Postoperative complicationThrough 6 weeks postoperativelyPostoperative incisional infection, postoperative incisional hernia
Fascial closure operating timeDuration of fascial closure operating timeTiming of fascial closure will start when the surgeon or surgical assistant reports s/he is beginning the fascial closure and stop after the suture is cut after tying.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026